Two ro (ss‐a) autoantibody responses in systemic lupus erythematosus

Arthritis & Rheumatism

Volumn 31, Issue 4, 1988, Pages 496-505

  Hamilton, Robert G ^a,c   Harley, John B ^a,b,c   Bias, Wilma B ^a,c   Roebber, Marianne ^a,c   Reichlin, Morris ^a,b,c   Hochberg, Marc C ^a,c   Arnett, Frank C ^a,c  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF OKLAHOMA   (United States)

^c DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; FEMALE; HLA SYSTEM; HUMAN; MAJOR CLINICAL STUDY; MALE; RO(SSA) ANTIBODY; SYSTEMIC LUPUS ERYTHEMATOSUS;

AUTOANTIBODIES; AUTOANTIGENS; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPES; HETEROZYGOTE; HLA-D ANTIGENS; HLA-DQ ANTIGENS; HLA-DR ANTIGENS; HUMAN; LUPUS ERYTHEMATOSUS, SYSTEMIC; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, NON-P.H.S.; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0023913871     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.1780310406     Document Type: Article

References (46)

1. Histocompatibility (HLA) antigens associated with systemic lupus erythematosus: a possible genetic predisposition to disease
2. Histocompatibility antigens in systemic lupus erythematosus
3. Disease associations of the la‐like human alloantigens: contrasting patterns in rheumatoid arthritis and systemic lupus erythematosus
4. Interrelationships of HLA‐DR, MB, and MT phenotypes, autoantibody expression, and clinical features in systemic lupus erythematosus
5. Relationships of HLA‐DR and MT antigens to autoantibody expression in systemic lupus erythematosus (letter)
6. Associations between systemic lupus erythematosus and the major histocompatibility complex: clinical and immunological considerations
7. Family study of the major histocompatibility complex in patients with systemic lupus erythematosus: importance of null alleles of C4A and C4B in determining disease susceptibility
8. Relationship between C4 null genes, HLA‐D region antigens and genetic susceptibility to systemic lupus erythematosus in Caucasian and black Americans
9. Serologic and HLA associations in subacute cutaneous lupus erythematosus, a clinical subset of lupus erythematosus
10. Homozygous C2 deficiency, lupus erythematosus, and anti‐Ro (SSA) antibodies
11. Neonatal lupus erythematosus: a clinical, serological and immunogenetic study with review of the literature
12. Serologic subsets in systemic lupus erythematosus: an examination of autoantibodies in relationship to clinical features of disease and HLA antigens
13. Sjögren's syndrome: influence of multiple HLA‐D region alloantigens on clinical and serologic expression
14. Quantitation and detection of isotypes of anti‐SS‐B antibodies by ELISA and Farr assays using affinity purified antigens: an approach to the investigation of Sjögren's syndrome and systemic lupus erythematosus
15. Molecular properties of the Ro(SS‐A) antigen and ELISA for quantitation of antibody
16. Anti‐La/SS‐B antibody is present in some normal sera and is coincident with anti‐Ro/SS‐A precipitins in systemic lupus erythematosus
17. Anti‐Ro (SS‐A) and anti‐La (SS‐B) in patients with Sjögren's syndrome
18. Antibodies to nRNP, Sm, Ro(SSA) and La(SSB) detected by ELISA: their specificity and inter‐relations in connective tissue disease sera
19. Quantitation of antibodies to nucleoribonucleoproteins by ELISA: relation between antibody levels and disease activity in patients with connective tissue disease
20. Gene interaction at HLA‐DQ enhances autoantibody production in primary Sjögren's syndrome
21. The 1982 revised criteria for the classification of systemic lupus erythematosus
22. Systemic lupus erythematosus: a review of clinico‐laboratory features and immunogenetic markers in 150 patients with emphasis on demographic subsets
23. Characterization of a soluble cytoplasmic antigen reactive with sera from patients with systemic lupus erythematosus
24. Heterogeneity of RNA protein antigens reactive with sera of patients with systemic lupus erythematosus: description of a cytoplasmic nonribosomal antigen
25. Precipitating antibody to DNA detected by two‐stage electroimmuno‐diffusion
26. Immunologic and structural studies of the lupus/Sjögren's syndrome autoantibody, La/SSB, with a monoclonal antibody
27. Affinity purification and immunoassay of anti‐Ro/SSA
28. Implications of anti‐Ro/SSA autoantibody in normal sera for lupus and Sjögren's syndrome
29. Application of personal computer integrated software to the immunoassay laboratory
30. HLA DR characterization of a Chippewa Indian subpopulation with high prevalence of rheumatoid arthritis
31. Clinical and serological differences between systemic lupus erythematosus patients with antibodies to Ro versus patients with antibodies to Ro and La
32. Anti‐RNA proteins in SLE (abstract)
33. HLA associations with the titers of anti‐RNA‐protein in SLE (abstract)
34. The frequency of SLE autoantibodies in normal sera and correlations with class II HLA antigens (abstract)
35. The Ro small cytoplasmic ribonucleoproteins: identification of the antigenic protein and its binding site on the Ro RNA's
36. La antigen recognizes and binds to the 3‐oligouridylate tail of a small RNA
37. Ro small cytoplasmic ribonucleoproteins are a subclass of La ribonucleoproteins: further characterization of the Ro and La small ribonucleoproteins from uninfected mammalian cells
38. Genes for two small cytoplasmic Ro RNAs are adjacent and appear to be single‐copy in the human genome
39. Structure, function and genetics of human class II molecules
40. Allelic polymorphism and transassociation of molecules encoded by the HLA‐DQ subregion
41. An influenza A virus‐specific and HLA‐DRw8‐restricted T cell clone cross‐reacting with a transcomplementation product of the HLA‐DR2 and DR4 haplotypes